Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People
July 21, 2014
TheStreet / Powered by NewsLook.com
New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York.
Video provided by TheStreet
AFP (Apr. 8, 2013) South Africa's health minister launches a new single dose anti-AIDS drug, which reduces the need for HIV positive patients to take multiple pills each day. The country has the largest HIV positive ... watch video
NDTV (May 7, 2013) It is not a girl's world, at least not in India where there are only 919 girls under six for every 1000 boys. The 2011 census figures show the ratio has fallen further from the already alarming 927 ... watch video
Newsy (July 10, 2014) The anonymous infant's "functional cure" last year raised hopes of a treatment for HIV-positive babies, but the virus finally re-emerged in the girl.
Video provided by ... watch video
FORA.tv (May 9, 2013) Dr Joep Lange has been involved in HIV research and treatment since 1983. He has been the architect and principal investigator of several pivotal trials on antiretroviral therapy and on the ... watch video
Newsy (July 22, 2015) Eli Lilly is debuting solanezumab, its new drug designed to cure Alzheimer's. But will the drug fare better than past trials have foreshadowed?
Video provided by ... watch video
AFP (May 5, 2015) An Austrian men's magazine has printed its latest edition using blood from people who are HIV-positive in order to counter the "stigma" often attached to the virus, its chief editor said Tuesday. ... watch video
Aug. 31, 2015 When we move our head, the whole visual world moves across our eyes. Yet we can still make out a bee buzzing by or a hawk flying overhead, thanks to unique cells in the eye ... read more
Aug. 31, 2015 The therapeutic effect of CD47 blockade as a cancer treatment relies more on dendritic cells than macrophages, scientists report. Anti-CD47-mediated tumor rejection will require both innate and ... read more
Aug. 31, 2015 In animals, numerous behaviors are governed by the olfactory perception of their surrounding world. Whether originating in the nose of a mammal or the antennas of an insect, ... read more
Aug. 31, 2015 Women aged 45 years and under with diabetes have a six-fold risk of heart attack, according to new research. The study in more than 7,000 women also found that young women who had a heart attack ... read more
Aug. 31, 2015 Epigenomic changes induced by pathogen infections, mediated by a transcription factor called ATF7, are the underlying mechanism of the memory of innate immunity, new research ... read more
Mar. 31, 2015 HIV (human immunodeficiency virus)-positive kidney transplant patients experienced superior outcomes when compared to kidney transplant patients with Hepatitis C and those infected with both HIV and ... read more
July 23, 2014 Treatment of HIV patients co-infected with the hepatitis C virus (HCV) with an anti-retroviral drug therapy not only tackles HIV, but also reduces HCV replication, according to a new ... read more
Jan. 15, 2014 Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans than HIV/AIDS, are about to get simpler and more effective, according to new ... read more
Feb. 1, 2011 Researchers examined the role of later acquisition of hepatitis C in HIV patients in a new study. The findings suggest HIV patients should have access to ongoing screening for hepatitis ... read more